About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Quant ESG Equity Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesDLF Limited9.246234613527.6164
Domestic EquitiesBajaj Auto Limited8.88373082826.5337
Domestic EquitiesPfizer Ltd8.36414450524.9820
Domestic EquitiesLife Insurance Corporation Of India7.988925000023.8613
Domestic EquitiesZydus Wellness Ltd7.570711599622.6123
Domestic EquitiesJio Financial Services Limited7.472977864622.3199
Domestic EquitiesHDFC Life Insurance Co Ltd6.690525723219.9831
Domestic EquitiesDivi's Laboratories Limited6.24052819018.6392
Domestic EquitiesTata Power Company Limited5.542842146516.5551
Domestic EquitiesAurobindo Pharma Limited4.288611159712.8091
Domestic EquitiesAditya Birla Lifestyle Brands Limited4.286974900012.8042
Domestic EquitiesAdani Power Limited3.27191797059.7724
Domestic EquitiesAdani Energy Solutions Limited3.25181120009.7126
Domestic EquitiesHFCL Limited3.108510600009.2845
Total 86.2080 257.4858
Cash & Cash Equivalents and Net AssetsTREPS 02-Jun-2025 DEPO 107.58832267222.6647
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-10.4363 -31.1712
Total -2.8480 -8.5065
Treasury Bills91 Days Treasury Bill 12-Jun-20251.67095000004.9907
Treasury Bills91 Days Treasury Bill 21-Aug-20250.99193000002.9627
Treasury Bills91 Days Treasury Bill 17-Jul-20250.66482000001.9857
Treasury Bills91 Days Treasury Bill 19-Jun-20250.33381000000.9970
Total 3.6615 10.9361
Derivatives-FuturesColgate-Palmolive (India) Ltd 26/06/20255.18206265015.4777
Derivatives-FuturesSun Pharmaceutical Industries Limited 26/06/20252.9067514508.6817
Derivatives-FuturesLupin Limited 26/06/20252.6563403757.9337
Derivatives-FuturesAurobindo Pharma Limited 26/06/20252.2336577506.6713
Total 12.9786 38.7644
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.